Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
Total Receivables
Maccura Biotechnology Co Ltd
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
Total Receivables
¥2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Total Receivables
¥10.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Total Receivables
¥3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Total Receivables
¥6.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Total Receivables
¥3.7B
|
CAGR 3-Years
34%
|
CAGR 5-Years
34%
|
CAGR 10-Years
35%
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Total Receivables
¥864.5m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Maccura Biotechnology Co Ltd's Total Receivables?
Total Receivables
2B
CNY
Based on the financial report for Mar 31, 2024, Maccura Biotechnology Co Ltd's Total Receivables amounts to 2B CNY.
What is Maccura Biotechnology Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
2%
Over the last year, the Total Receivables growth was -2%. The average annual Total Receivables growth rates for Maccura Biotechnology Co Ltd have been -4% over the past three years , 2% over the past five years .